BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3891937)

  • 1. The patho-epidemiology of benign proliferative epithelial disorders of the female breast.
    Cook MG; Rohan TE
    J Pathol; 1985 May; 146(1):1-15. PubMed ID: 3891937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menstrual and reproductive history, postmenopausal hormone use, and risk of benign proliferative epithelial disorders of the breast: a cohort study.
    Cui Y; Page DL; Lane DS; Rohan TE
    Breast Cancer Res Treat; 2009 Mar; 114(1):113-20. PubMed ID: 18360772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond fibrocystic disease. The evolving concept of pre-malignant breast disease.
    Shirley SE
    West Indian Med J; 1999 Dec; 48(4):173-8. PubMed ID: 10639833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cigarette smoking and risk of benign proliferative epithelial disorders of the breast in the Women's Health Initiative.
    Cui Y; Page DL; Chlebowski RT; Hsia J; Allan Hubbell F; Johnson KC; Rohan TE
    Cancer Causes Control; 2007 May; 18(4):431-8. PubMed ID: 17323143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types.
    Marshall LM; Hunter DJ; Connolly JL; Schnitt SJ; Byrne C; London SJ; Colditz GA
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):297-301. PubMed ID: 9149887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case-control study of diet and benign proliferative epithelial disorders of the breast.
    Rohan TE; Cook MG; Potter JD; McMichael AJ
    Cancer Res; 1990 Jun; 50(11):3176-81. PubMed ID: 2334913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomorphology of fibrocystic change, high-risk proliferative breast disease, and premalignant breast lesions.
    Masood S
    Clin Lab Med; 2005 Dec; 25(4):713-31, vi. PubMed ID: 16308088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer.
    Worsham MJ; Raju U; Lu M; Kapke A; Cheng J; Wolman SR
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5474-9. PubMed ID: 17875777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cohort study of oral contraceptive use and risk of benign breast disease.
    Rohan TE; Miller AB
    Int J Cancer; 1999 Jul; 82(2):191-6. PubMed ID: 10389751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial dysplasia in nipple aspirates of breast fluid: association with family history and other breast cancer risk factors.
    Petrakis NL; Ernster VL; King EB; Sacks ST
    J Natl Cancer Inst; 1982 Jan; 68(1):9-13. PubMed ID: 6948129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for premalignant lesions in the human breast.
    Sloane JP
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():17-21. PubMed ID: 8298446
    [No Abstract]   [Full Text] [Related]  

  • 12. Frequency of benign and preinvasive breast diseases.
    Altaf FJ; Abdullah LS; Jamal AA
    Saudi Med J; 2004 Apr; 25(4):493-7. PubMed ID: 15083223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of risk factors in counseling patients.
    Love SM
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):599-610. PubMed ID: 2691491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological pattern of benign breast disease as a risk factor for invasive breast cancer.
    Bianchi S; del Turco MR; Simoncini R; Distante V; Russo A; Palli D
    Cancer Detect Prev; 1992; 16(1):17-9. PubMed ID: 1551133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol consumption and risk of benign proliferative epithelial disorders of the breast in women.
    Rohan TE; Cook MG
    Int J Cancer; 1989 Apr; 43(4):631-6. PubMed ID: 2703271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of proliferative breast lesions around breast cancers].
    Moriya T; Manabe T; Sakurai T; Sakamoto K
    Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():42-5. PubMed ID: 7747991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial.
    Rohan TE; Negassa A; Chlebowski RT; Habel L; McTiernan A; Ginsberg M; Wassertheil-Smoller S; Page DL
    J Natl Cancer Inst; 2008 Apr; 100(8):563-71. PubMed ID: 18398105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between component parts of fibrocystic disease complex and breast cancer.
    Page DL; Vander Zwaag R; Rogers LW; Williams LT; Walker WE; Hartmann WH
    J Natl Cancer Inst; 1978 Oct; 61(4):1055-63. PubMed ID: 279711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preneoplasia of the breast.
    Böcker W
    Verh Dtsch Ges Pathol; 1997; 81():502-13. PubMed ID: 9474891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papillary apocrine change of the breast: associations with atypical hyperplasia and risk of breast cancer.
    Page DL; Dupont WD; Jensen RA
    Cancer Epidemiol Biomarkers Prev; 1996 Jan; 5(1):29-32. PubMed ID: 8770463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.